Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition

Journal of Molecular and Cellular Cardiology

27 June Jun 2016 5 months ago
  • Songia P, Myasoedova V, Alamanni F, Tremoli E, Poggio P

Mitral valve prolapse (MVP) has a prevalence of 3% in the general population, affecting >176 million people worldwide. Despite this, little is known about the molecular and cellular mechanisms involved in the progression of MVP and surgical intervention is the only available option. In this study we investigated the role of osteoprotegerin (OPG) during endothelial to mesenchymal transition (EndMT) in MVP.

Reference
Songia P, Branchetti E, Parolari A, Myasoedova V, Ferrari G, Alamanni F, Tremoli E, Poggio P. Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. J Mol Cell Cardiol 2016 Jun 20 [Epub ahead of print]

Go to PubMed